- Home
- NBY vs TTNP Comparison
NBY vs TTNP Comparison
Compare NBY & TTNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBY
- TTNP
- Stock Information
- Founded
- NBY 2000
- TTNP 1991
- Country
- NBY United States
- TTNP United States
- Employees
- NBY N/A
- TTNP N/A
- Industry
- NBY
- TTNP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NBY
- TTNP Health Care
- Exchange
- NBY Nasdaq
- TTNP Nasdaq
- Market Cap
- NBY 3.3M
- TTNP 3.3M
- IPO Year
- NBY 2007
- TTNP 1996
- Fundamental
- Price
- NBY $0.53
- TTNP $3.53
- Analyst Decision
- NBY Strong Buy
- TTNP
- Analyst Count
- NBY 1
- TTNP 0
- Target Price
- NBY $0.85
- TTNP N/A
- AVG Volume (30 Days)
- NBY 77.8K
- TTNP 28.0K
- Earning Date
- NBY 11-07-2024
- TTNP 12-27-2024
- Dividend Yield
- NBY N/A
- TTNP N/A
- EPS Growth
- NBY N/A
- TTNP N/A
- EPS
- NBY N/A
- TTNP N/A
- Revenue
- NBY $13,844,000.00
- TTNP $3,000.00
- Revenue This Year
- NBY N/A
- TTNP N/A
- Revenue Next Year
- NBY $26.04
- TTNP N/A
- P/E Ratio
- NBY N/A
- TTNP N/A
- Revenue Growth
- NBY 15.40
- TTNP N/A
- 52 Week Low
- NBY $0.36
- TTNP $3.24
- 52 Week High
- NBY $10.15
- TTNP $14.80
- Technical
- Relative Strength Index (RSI)
- NBY 35.25
- TTNP 40.85
- Support Level
- NBY $0.52
- TTNP $3.25
- Resistance Level
- NBY $0.58
- TTNP $3.85
- Average True Range (ATR)
- NBY 0.03
- TTNP 0.36
- MACD
- NBY -0.00
- TTNP -0.00
- Stochastic Oscillator
- NBY 11.56
- TTNP 24.76
About NBY NovaBay Pharmaceuticals Inc.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically eyecare and skincare products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease. It has two reportable segments: Eyecare and Wound Care and Skincare.
About TTNP Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.